questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the typical duration and severity of withdrawal symptoms associated with dopamine agonist dose reduction or discontinuation; and how those outcomes vary by starting dose, indication and duration of exposure.
heading: Drugs: Side Effects